Press Releases

LOS ANGELES, Oct. 10, 2019 /PRNewswire/ -- Award-winning wellness company dosist today announced the launch of its revolutionary new product, the dose dial™, the first dose-controlle

JERUSALEM, Oct. 10, 2019 /PRNewswire/ -- Future Meat Technologies today announced it has closed a $14 million Series A funding round led by S2G Ventures, a Chicago-based venture capital firm and one of the forces behind Beyond Meat's IPO, and Emerald Technology Ventures, a Swiss-based ven

SAN DIEGO, Oct. 10, 2019 /PRNewswire/ -- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, today announced Kerry Ingalls has joined the company as Chief Operating Officer. In this role, Ingalls will work closely with

YOQNEAM, Israel, Oct. 10, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it will release its results for the third quarter of 2019 before the Nasdaq market opens on Tuesday, November 5, 2019.

SALT LAKE CITY, Oct. 10, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), clinical-stage biopharmaceutical company, announced today that Dr. Mahesh Patel, Chairman,

REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 10, 2019 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) ("Foamix" or the "Company"), a clinical stage specialty pharmaceutical company, today announced it will present results from nine clinical trials in five posters relating to its investigational topical product candidates FMX101

SAN MARCOS, Calif., Oct. 10, 2019 /PRNewswire/ -- PACE®, which stands for Program of All-inclusive Care for the Elderly, has come to north San Diego County with the official ribbon-cutting today of the nonprofit

MISSOULA, Mont., Oct. 10, 2019 /PRNewswire/ -- FYR Diagnostics LLC, a privately held, Montana-based company focused on developing novel diagnostic technologies, today announced that the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded the company

$10,000 Scholarships Awarded to Nine Students Affected by Dermatologic Conditions LAVAL, Quebec, Oct. 10, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the 2019 Aspire Highe

DALLAS, Oct. 10, 2019 /PRNewswire/ -- Phynd Technologies, a leading provider information management vendor, announced today a partnership with